SMS Clinical Research

01/26/2026

Tired of treatments that fail your child's Eczema? Our Amlitelimab study is testing a promising pathway to relief. Access innovative care and compensation today. Enroll Now: smsclinicalresearch.com/eczema

01/23/2026

🧬 Now Enrolling: COVID-19 Vaccine Clinical Trial for Adults 50–64 💉
SMS Clinical Research is conducting a new clinical trial focused on evaluating a COVID-19 vaccine designed specifically for healthy adults ages 50 to 64.

📍 Location: 400 W. Kearney St, Mesquite, TX
💰 Compensation: Up to $750
🗓️ Visit Requirement: 1–4 in-person visits, no long-term follow-up

By joining, you’re helping shape the future of public health—while receiving expert care and contributing to life-saving vaccine research.
✅ Safe
✅ Simple
✅ Impactful

01/23/2026

01/21/2026

We have 2 current heart studies enrolling now. One is a preventative for men >55 & women >65 at high risk of cardiovascular conditions while the other is for high cholesterol in addition to other high risk conditions & can include patients with cardiac history. Call us today at 972-216-5100

Fewer people are dying from heart disease, but the condition is still the leading cause of death in the U.S., a new report from the American Heart Association finds.

Although death rates from heart disease have dropped for the first time in the past five years, it still kills more Americans than any other condition, according to the report, published early Wednesday in the journal Circulation.

Read more: https://abcnews.visitlink.me/Fr22yh

01/21/2026

SMS Clinical Research is enrolling adults ages 18–65 diagnosed with APOL1-mediated CKD. This Phase 2b trial tests AZD2373, a treatment designed to target the genetic cause of the disease and potentially slow its progression. Participants attend routine visits for injections, health monitoring, kidney function tests, and lab work — all overseen by doctors specializing in kidney care. Your participation helps advance kidney disease research for yourself and future patients.

Call (972) 216-5100 today to check eligibility or learn more.

01/20/2026

Good advice-Stay warm out there!

With cold temperatures in North Texas, it’s time to remember the 4 Ps of Winter Preparedness:
• People: Check on neighbors, friends and family to ensure they are staying warm and safe.
• Pets: Bring pets indoors or provide adequate shelter and warmth if they absolutely must stay outside.
• Plants: Cover outdoor plants or bring them inside.
• Pipes: Insulate exposed pipes to prevent freezing and disconnect outdoor hoses. Leave indoor faucets at a drip.

01/19/2026

Today we pause to honour Dr. Martin Luther King Jr., a voice that moved generations and a legacy that continues to inspire change.
May his message of justice, equality, and hope guide us forward.

01/16/2026

If reflux, burning, or that lingering discomfort keeps showing up, this study may offer a different kind of relief.

✔️ No-cost care and monitoring
✔️ Potential compensation for participants
✔️ Open to adults with frequent heartburn or reflux symptoms

A chance to explore a gentler, investigational approach—while helping move digestive health research forward.

01/14/2026

Breathing shouldn’t feel like a daily struggle. SMS Clinical Research is studying a new treatment for moderate to severe COPD to see if it can reduce flare-ups, improve lung function, and make everyday breathing easier. This Phase III trial includes lung function tests, symptom check-ins, and ongoing support from our clinical team. If you’ve been living with coughing, mucus, or shortness of breath that keeps interrupting your life, this study may be a chance to try something new while helping advance COPD care for millions.

Call (972) 216-5100 today to learn more or check your eligibility.

01/12/2026

If you’re living with moderate to severe Crohn’s disease and current medications aren’t giving you enough relief, this study may offer a new direction. SMS Clinical Research is testing an investigational treatment designed to reduce inflammation, support remission, and improve long-term gut health. Participants receive structured medical care, imaging, lab checks, and close monitoring throughout the study — along with compensation for their time and commitment.

Call (972) 216-5100 to learn more or check your eligibility.

01/09/2026

Managing diabetes shouldn’t feel like guesswork. SMS Clinical Research is enrolling adults with Type 1 or Type 2 diabetes who use insulin for a study testing the latest FreeStyle Libre continuous glucose monitoring device. Participants wear the sensor, attend study visits, and receive careful medical oversight from our team.

You’ll help shape the future of diabetes care — and compensation of $2,500+ is provided for your time.

01/08/2026

SMS Clinical Research is enrolling non-pregnant biological females 12+ for a Phase 3 Vaginal Yeast Infection Treatment Study. This investigational vaginal capsule is taken daily for 14 days, with full support from our medical team, follow-up visits, and safety checks.

If you’re experiencing symptoms now, you may qualify — and participants may receive up to $462 for their time.

Call (972) 216-5100 to see if you qualify and start enrolling today.